Biohaven Pharmaceutical Holding Company Ltd. (BHVN) financial statements (2022 and earlier)

Company profile

Business Address 215 CHURCH STREET
NEW HAVEN, CT 06510
State of Incorp.
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments355317264131
Cash and cash equivalents132317264131
Short-term investments223   
Restricted cash and investments1   
Receivables120   
Inventory, net of allowances, customer advances and progress billings40   
Inventory40   
Prepaid expense 475
Other current assets15000
Other undisclosed current assets73800
Total current assets:603328272137
Noncurrent Assets
Operating lease, right-of-use asset6 
Property, plant and equipment9862
Long-term investments and receivables15118
Long-term investments15118
Intangible assets, net (including goodwill)39   
Intangible assets, net (excluding goodwill)39   
Restricted cash and investments1   
Other undisclosed noncurrent assets27200
Total noncurrent assets:84161810
TOTAL ASSETS:687344290147
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities21466209
Accounts payable4814115
Accrued liabilities1665295
Financial instruments subject to mandatory redemption, settlement terms, share value, amount63   
Total current liabilities:27766209
Noncurrent Liabilities
Long-term debt and lease obligation11   
Finance lease, liability8 
Operating lease, liability3 
Liabilities, other than long-term debt14714121
Financial instruments subject to mandatory redemption, settlement terms, share value, amount112104  
Other liabilities21021
Derivative instruments and hedges, liabilities1438  
Other undisclosed noncurrent liabilities5851441184
Total noncurrent liabilities:7422861205
Total liabilities:1,01935213915
Temporary equity, carrying amount60   
Stockholders' equity
Stockholders' equity attributable to parent(390)(7)151132
Common stock1,250881554311
Additional paid in capital99844024
Accumulated other comprehensive income0   
Accumulated deficit(1,739)(972)(444)(203)
Stockholders' equity attributable to noncontrolling interest(2)   
Total stockholders' equity:(392)(7)151132
TOTAL LIABILITIES AND EQUITY:687344290147

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues64   
Cost of revenue
(Cost of Goods and Services Sold)
(18)   
Gross profit:46   
Operating expenses(691)(479)(225)(108)
Operating loss:(645)(479)(225)(108)
Nonoperating expense(113)(49)(16)(19)
Other nonoperating expense(4)(0)(0)(19)
Interest and debt expense(0)(13)(0)(1)
Other undisclosed income from continuing operations before equity method investments, income taxes 1301
Loss from continuing operations before equity method investments, income taxes:(759)(528)(240)(126)
Other undisclosed income from continuing operations before income taxes0   
Loss from continuing operations before income taxes:(758)(528)(240)(126)
Income tax expense(10)(0)(0)(1)
Net loss:(769)(529)(241)(127)
Net income attributable to noncontrolling interest2   
Net loss attributable to parent:(767)(529)(241)(127)
Other undisclosed net loss available to common stockholders, basic   (12)
Net loss available to common stockholders, diluted:(767)(529)(241)(139)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net loss:(769)(529)(241)(127)
Other comprehensive income0   
Comprehensive loss:(768)(529)(241)(127)
Comprehensive income, net of tax, attributable to noncontrolling interest2   
Comprehensive loss, net of tax, attributable to parent:(766)(529)(241)(127)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: